Numerous clinical studies have demonstrated the positive impact of Mesenchymal Stem Cell (MSC)-based therapies on osteoarthritis. In this article, we examine several of these studies, along with the functional and radiological improvements many OA patients have seen following MSC therapy.
One of the main advantages of Adult Stem Cell Banking with Celltex is that it gives you access to your body’s own Mesenchymal Stem Cells (MSCs) at quantities exponentially greater than what you’d receive through many of the regenerative medicine options currently out there.
In this article, we examine some recent research studies to identify the extra potential that comes with large quantities of your body’s stem cells.
A question we’re often asked is “If I receive stem cell therapy, how many times will I need to come back to get additional therapy?”
While the answer isn’t necessarily cut and dried, recent research, both from external studies and from Celltex’s client-reported results, may be able to help us begin to answer that question.
Existing research suggests that one’s own stem cells have the potential to help alleviate joint pain and prevent functional losses in cases of osteoarthritis.
James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the current treatment of athletic injuries.
Learn More